Morning Movers Gapping up $Tivic Health Systems (TIVC.US)$shares jumped 76% in Tuesday premarket after CEO Jennifer Ernst announced plans for 2025 cash flow initiatives and disease-specific clinical trials for regulatory approvals. $NeueHealth (NEUE.US)$stock surged 62% after announcing its agreement to be acquired and taken private by a New Enterprise Associates affiliate in a deal valued at approximately $1.3 billion. $SEALSQ Corp (LAES.US)$shares c...
$Cytokinetics (CYTK.US)$ Cytokinetics (CYTK) and Bayer have established an exclusive licensing agreement for aficamten in Japan, focusing on treating hypertrophic cardiomyopathy (HCM). The deal includes an upfront payment of €50 million to Cytokinetics, with potential additional earnings of €90 million in milestones through commercial launch (including €20 million near-term) and up to €490 million in commercial milestone payments. The collaboration involves tiered royalties on Japanese sales and ...
Top 5 Upgrades: Baird upgraded Starbucks$Starbucks (SBUX.US)$to Outperform from Neutral with a price target of $110, up from $81. The firm sees a more favorable risk/reward on Starbucks shares following the hiring of Brian Niccol as CEO. Barclays upgraded Dell Technologies$Dell Technologies (DELL.US)$to Equal Weight from Underweight with an unchanged price target of $97. The firm says much of the artificial intelligence "hype" ...
CEO's belief in the company's potential to grow independently may have led to a 3% stock dip. Speculation around a Novartis takeover, and its withdrawal, could have swayed investor sentiment.
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
Cytokinetics Stock Forum
Groundbreaking Healthcare Tool Unlocks Insights from 65,000 Pharmacies' HCM Data
Gapping up
$Tivic Health Systems (TIVC.US)$ shares jumped 76% in Tuesday premarket after CEO Jennifer Ernst announced plans for 2025 cash flow initiatives and disease-specific clinical trials for regulatory approvals.
$NeueHealth (NEUE.US)$ stock surged 62% after announcing its agreement to be acquired and taken private by a New Enterprise Associates affiliate in a deal valued at approximately $1.3 billion.
$SEALSQ Corp (LAES.US)$ shares c...
Cytokinetics (CYTK) and Bayer have established an exclusive licensing agreement for aficamten in Japan, focusing on treating hypertrophic cardiomyopathy (HCM). The deal includes an upfront payment of €50 million to Cytokinetics, with potential additional earnings of €90 million in milestones through commercial launch (including €20 million near-term) and up to €490 million in commercial milestone payments. The collaboration involves tiered royalties on Japanese sales and ...
Baird upgraded Starbucks $Starbucks (SBUX.US)$ to Outperform from Neutral with a price target of $110, up from $81. The firm sees a more favorable risk/reward on Starbucks shares following the hiring of Brian Niccol as CEO.
Barclays upgraded Dell Technologies $Dell Technologies (DELL.US)$ to Equal Weight from Underweight with an unchanged price target of $97. The firm says much of the artificial intelligence "hype" ...
$Merck & Co (MRK.US)$ x $Immunovant (IMVT.US)$
$Eli Lilly and Co (LLY.US)$ x $Cytokinetics (CYTK.US)$ (and soon)
$Regeneron Pharmaceuticals (REGN.US)$ x $Apellis Pharmaceuticals (APLS.US)$ (panache & brash)
$Gilead Sciences (GILD.US)$ x % $Madrigal Pharmaceuticals (MDGL.US)$ (liver king)
$Bristol-Myers Squibb (BMY.US)$ x $Iovance Biotherapeutics (IOVA.US)$ (cell Tx boost needed)
$Eli Lilly and Co (LLY.US)$ x $Merus (MRUS.US)$ (partner n...
No comment yet